A Rat Study on the PTEN Expression in Ovarian Tissue in PCOS and Folliculogenesis

Overview

Journal Sci Rep

Specialty Science

Date 2023 Nov 26

PMID 38008769

Authors

Muberra Namli Kalem

Elvan Anadol

Ziya Kalem

Perihan Yalcinkaya Sezginer

Cigdem Elmas

Canan Yilmaz

Batuhan Bakirarar

Affiliations

Soon will be listed here.

Abstract

The objective of this investigation was to examine alterations in PTEN expression within ovarian tissue in a rat model of polycystic ovary syndrome (PCOS). The analysis also encompassed the examination of PTEN alterations in the ovarian tissue throughout the process of folliculogenesis in rats with normal ovulatory cycles. The study involved 12 adult female Sprague‒Dawley rats randomly assigned to the letrozole-induced polycystic ovary syndrome (PCOS) group as part of an animal-based research endeavour. The sections derived from the ovaries were subjected to immunohistochemical staining for PTEN. The evaluation of PTEN staining levels in ovarian tissues was conducted using electron microscopy. Follicle counts, as well as hormonal and biochemical analyses (serum luteinising hormone (LH), follicle-stimulating hormone (FSH), anti-Müllerian hormone (AMH), testosterone, oestradiol levels and serum glucose, triglyceride, HDL and LDL-cholesterol levels), were conducted to provide evidence of the manifestation of polycystic ovary syndrome (PCOS) in rats. The number of primordial and Graafian follicles in the PCOS group decreased significantly, and the number of primary, secondary and antral follicles increased significantly. PTEN expression was found to be significantly higher in the PCOS group than in the control group in the primordial follicle oocyte cytoplasm, primordial follicle granulosa cells, primary follicle oocyte cytoplasm, primary follicle granulosa cells, antral follicle oocyte cytoplasm, antral follicle granulosa cells, and corpus luteum (p = 0.007, p = 0.001, p = 0.001, p = 0.001, p = 0.001, p = 0.002, and p = 0.018, respectively). In the non-PCOS group, a time-dependent comparison of the amount of oocyte cytoplasm and PTEN staining in granulosa cells of the oocytes at different stages of development was performed. While the follicles were developing from the primordial follicle to the primary and antral follicle, the amount of PTEN staining in the oocyte cytoplasm decreased, whereas the PTEN activity in the granulosa cells increased as the oocyte developed (p = 0.001 and p = 0.001, respectively). The current investigation demonstrated changes in PTEN expression in ovarian tissue throughout the course of normal folliculogenesis, as well as in instances of disrupted folliculogenesis, with a focus on rats with PCOS.

Citing Articles

Molecular crosstalk between insulin-like growth factors and follicle-stimulating hormone in the regulation of granulosa cell function.

Hayes E, Winston N, Stocco C Reprod Med Biol. 2024; 23(1):e12575.

PMID: 38571513 PMC: 10988955. DOI: 10.1002/rmb2.12575.

References

Yin Y, Shen W . PTEN: a new guardian of the genome. Oncogene. 2008; 27(41):5443-53. DOI: 10.1038/onc.2008.241. View

Feldman A, Wolfe D . Tissue processing and hematoxylin and eosin staining. Methods Mol Biol. 2014; 1180:31-43. DOI: 10.1007/978-1-4939-1050-2_3. View

Kranc W, Budna J, Kahan R, Chachula A, Bryja A, Ciesiolka S . Molecular basis of growth, proliferation, and differentiation of mammalian follicular granulosa cells. J Biol Regul Homeost Agents. 2017; 31(1):1-8. View

Andreas E, Hoelker M, Neuhoff C, Tholen E, Schellander K, Tesfaye D . MicroRNA 17-92 cluster regulates proliferation and differentiation of bovine granulosa cells by targeting PTEN and BMPR2 genes. Cell Tissue Res. 2016; 366(1):219-30. DOI: 10.1007/s00441-016-2425-7. View

He T, Liu Y, Zhao S, Liu H, Wang Z, Shi Y . Comprehensive assessment the expression of core elements related to IGFIR/PI3K pathway in granulosa cells of women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2018; 233:134-140. DOI: 10.1016/j.ejogrb.2018.12.010. View

Baravalle C, Salvetti N, Mira G, Pezzone N, Ortega H . Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch Med Res. 2006; 37(7):830-9. DOI: 10.1016/j.arcmed.2006.04.006. View

Gu L, Liu H, Gu X, Boots C, Moley K, Wang Q . Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes. Cell Mol Life Sci. 2014; 72(2):251-71. PMC: 4389777. DOI: 10.1007/s00018-014-1739-4. View

Azziz R . PCOS in 2015: New insights into the genetics of polycystic ovary syndrome. Nat Rev Endocrinol. 2016; 12(2):74-5. DOI: 10.1038/nrendo.2015.230. View

Dewailly D, Robin G, Peigne M, Decanter C, Pigny P, Catteau-Jonard S . Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update. 2016; 22(6):709-724. DOI: 10.1093/humupd/dmw027. View

10.

Zhou Z, Tu Z, Zhang J, Tan C, Shen X, Wan B . Follicular Fluid-Derived Exosomal MicroRNA-18b-5p Regulates PTEN-Mediated PI3K/Akt/mTOR Signaling Pathway to Inhibit Polycystic Ovary Syndrome Development. Mol Neurobiol. 2022; 59(4):2520-2531. DOI: 10.1007/s12035-021-02714-1. View

11.

Gundersen H, Jensen E . The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987; 147(Pt 3):229-63. DOI: 10.1111/j.1365-2818.1987.tb02837.x. View

12.

Gougeon A . Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996; 17(2):121-55. DOI: 10.1210/edrv-17-2-121. View

13.

Onal T, Tulay P, Vatansever H . Does Pten have an impact on oogenesis of PCOS mouse models?. Zygote. 2022; 31(1):97-100. DOI: 10.1017/S0967199422000661. View

14.

Iwase A, Goto M, Harata T, Takigawa S, Nakahara T, Suzuki K . Insulin attenuates the insulin-like growth factor-I (IGF-I)-Akt pathway, not IGF-I-extracellularly regulated kinase pathway, in luteinized granulosa cells with an increase in PTEN. J Clin Endocrinol Metab. 2009; 94(6):2184-91. DOI: 10.1210/jc.2008-1948. View

15.

Kafali H, Iriadam M, Ozardali I, Demir N . Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res. 2004; 35(2):103-8. DOI: 10.1016/j.arcmed.2003.10.005. View

16.

Xie F, Zhang J, Zhai M, Liu Y, Hu H, Yu Z . Melatonin ameliorates ovarian dysfunction by regulating autophagy in PCOS via the PI3K-Akt pathway. Reproduction. 2021; 162(1):73-82. DOI: 10.1530/REP-20-0643. View

17.

Hsueh A, Kawamura K, Cheng Y, Fauser B . Intraovarian control of early folliculogenesis. Endocr Rev. 2014; 36(1):1-24. PMC: 4309737. DOI: 10.1210/er.2014-1020. View

18.

He T, Sun Y, Zhang Y, Zhao S, Zheng Y, Hao G . MicroRNA-200b and microRNA-200c are up-regulated in PCOS granulosa cell and inhibit KGN cell proliferation via targeting PTEN. Reprod Biol Endocrinol. 2019; 17(1):68. PMC: 6698342. DOI: 10.1186/s12958-019-0505-8. View

19.

Munakata Y, Kawahara-Miki R, Shiratsuki S, Tasaki H, Itami N, Shirasuna K . Gene expression patterns in granulosa cells and oocytes at various stages of follicle development as well as in in vitro grown oocyte-and-granulosa cell complexes. J Reprod Dev. 2016; 62(4):359-66. PMC: 5004791. DOI: 10.1262/jrd.2016-022. View

20.

Courtney K, Corcoran R, Engelman J . The PI3K pathway as drug target in human cancer. J Clin Oncol. 2010; 28(6):1075-83. PMC: 2834432. DOI: 10.1200/JCO.2009.25.3641. View